Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-22 Purchase |
2022-11-28 4:33 pm |
Lipocine Inc. | LPCN | Papapetropoulos Spyros Director |
21,739 | $0.47 | $10,217 | 21,739 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-22 9:45 pm |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer |
300 | $14 | $4,200 | 153,604 (Direct) |
View |
| 2022-05-03 Purchase |
2022-05-04 07:00 am |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer |
4,000 | $3.3978 | $13,591 | 4,000 (Direct) |
View |
| 2021-03-11 Purchase |
2021-03-15 3:24 pm |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
5,975 | $5.06 | $30,233 | 15,975 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-16 Option Award |
2025-04-18 08:04 am |
N/A 2035-04-16 |
Neuphoria Therapeutics Inc. | NEUP | Papapetropoulos Spyros President and CEO |
270,000 | $5.16 | 282,529 (Direct) |
View |
Ownership |
2024-07-08 06:10 am |
N/A N/A |
BIONOMICS LIMITED | BNOX | Papapetropoulos Spyros Chief Executive Officer |
0 | $0 | 33,066,955 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:48 pm |
2025-06-05 2034-06-05 |
Lipocine Inc. | LPCN | Papapetropoulos Spyros Director |
1,764 | $7.05 | 5,410 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:37 pm |
2024-05-10 2033-05-10 |
Lipocine Inc. | LPCN | Papapetropoulos Spyros Director |
30,000 | $0.2656 | 62,000 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-22 9:45 pm |
N/A 2030-11-18 |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer |
300 | $0 | 153,604 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-22 9:45 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer |
300 | $1.89 | 153,604 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 11:34 am |
2023-06-08 2032-06-08 |
Lipocine Inc. | LPCN | Papapetropoulos Spyros Director |
22,000 | $0.92 | 32,000 (Direct) |
View |
| 2022-04-11 Option Award |
2022-04-12 5:00 pm |
2023-04-11 2032-04-11 |
Lipocine Inc. | LPCN | Papapetropoulos Spyros Director |
10,000 | $1.16 | 10,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:05 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer |
75,500 | $0 | 75,500 (Direct) |
View |
Ownership |
2022-01-06 8:31 pm |
N/A 2030-11-18 |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer |
0 | $0 | 293,004 (Direct) |
View |
| 2021-11-24 Equity Swap |
2021-11-24 4:09 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
20,975 | $0 | 0 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:16 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
15,000 | $0 | 30,975 (Direct) |
View |
| 2020-11-22 Option Award |
2020-11-24 5:57 pm |
N/A 2030-11-21 |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-11-24 5:52 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
0 | $0 | 0 (Direct) |
View |